Security key
45258H106
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,769,253
- Total 13F shares
- 27,077,219
- Share change
- +1,770,592
- Total reported value
- $246,615,159
- Put/Call ratio
- 352%
- Price per share
- $9.11
- Number of holders
- 76
- Value change
- +$26,862,251
- Number of buys
- 48
- Number of sells
- 24
Report period
Q1 2026
Institutions
76
Top holders
10
IMMX full security history
Previous quarter: Q4 2025
Immix Biopharma, Inc. SEC filings
Immix Biopharma, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45258H106
Recent filing periods:
Top shareholders of IMMX - Immix Biopharma, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
9.1%
|
4,802,002
|
$46,531,399 | +$8,531,405 | 31 Mar 2026 | |
| Saturn V Capital Management LP |
13D/G
13F
|
Company |
7%
|
3,693,585
|
$17,987,759 | $0 | 26 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
3.3%
|
1,750,200
|
$16,959,438 | -$10,291,071 | 31 Mar 2026 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
4.8%
|
2,549,019
|
$13,331,369 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.7%
|
1,978,743
|
$10,348,824 | — | 31 Dec 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
2.8%
|
1,500,000
|
$7,845,000 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.1%
|
1,095,814
|
$5,731,107 | — | 31 Dec 2025 | |
| Bleichroeder LP |
13F
|
Company |
1.9%
|
1,000,000
|
$5,230,000 | — | 31 Dec 2025 | |
| Logos Global Management LP |
13F
|
Company |
1.9%
|
1,000,000
|
$5,230,000 | — | 31 Dec 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
1.9%
|
986,240
|
$5,158,035 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.9%
|
980,392
|
$5,127,450 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.86%
|
452,147
|
$2,364,729 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.75%
|
393,887
|
$2,060,029 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.64%
|
338,941
|
$1,772,661 | — | 31 Dec 2025 | |
| Burkehill Global Management, LP |
13F
|
Company |
0.56%
|
294,118
|
$1,538,237 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.49%
|
258,600
|
$1,352,478 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
246,056
|
$1,287,519 | — | 31 Dec 2025 | |
| KVP Capital Advisors, LP |
13F
|
Company |
0.44%
|
230,423
|
$1,205,112 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.39%
|
208,370
|
$1,089,775 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.32%
|
167,132
|
$874,101 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.25%
|
130,255
|
$681,233 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.24%
|
126,622
|
$662,232 | — | 31 Dec 2025 | |
| LGT Fund Management Co Ltd. |
13F
|
Company |
0.24%
|
125,000
|
$660,000 | — | 31 Dec 2025 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.23%
|
120,856
|
$632,077 | — | 31 Dec 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.22%
|
118,261
|
$618,505 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
100,658
|
$526,441 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
98,732
|
$516,366 | — | 31 Dec 2025 | |
| Longaeva Partners L.P. |
13F
|
Company |
0.19%
|
98,040
|
$512,749 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
97,360
|
$509,193 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.14%
|
75,338
|
$394,018 | — | 31 Dec 2025 | |
| OMERS ADMINISTRATION Corp |
13F
|
Company |
0.14%
|
74,700
|
$390,681 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.14%
|
73,791
|
$386,000 | — | 31 Dec 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.14%
|
73,570
|
$384,771 | — | 31 Dec 2025 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.13%
|
70,682
|
$369,667 | — | 31 Dec 2025 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.13%
|
68,550
|
$358,517 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
58,599
|
$306,473 | — | 31 Dec 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.09%
|
50,000
|
$261,500 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.09%
|
49,814
|
$260,527 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.09%
|
46,394
|
$242,641 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.08%
|
40,000
|
$209,200 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
35,000
|
$183,050 | — | 31 Dec 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.07%
|
35,000
|
$183,050 | — | 31 Dec 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
33,800
|
$176,774 | — | 31 Dec 2025 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.06%
|
33,649
|
$175,984 | — | 31 Dec 2025 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
0.06%
|
31,755
|
$166,079 | — | 31 Dec 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.06%
|
31,725
|
$165,923 | — | 31 Dec 2025 | |
| Concurrent Investment Advisors, LLC |
13F
|
Company |
0.05%
|
27,431
|
$143,464 | — | 31 Dec 2025 | |
| TritonPoint Partners, LLC |
13F
|
Company |
0.05%
|
24,526
|
$128,271 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.04%
|
22,120
|
$115,688 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
21,500
|
$112,445 | — | 31 Dec 2025 |
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2026
As of 31 Mar 2026,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,077,219 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, Saturn V Capital Management LP, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, Logos Global Management LP, Bleichroeder LP, FRANKLIN RESOURCES INC, and Velan Capital Investment Management LP.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
67
Q1 2026 holders
76
Holder diff
9
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.